As interest in high-oleic soybeans grows, dairy farmers must carefully evaluate roasting options to maximize feed quality and ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the oral Bruton's tyrosine kinase (BTK) inhibitor remibrutinib (Rhapsido, Novartis Pharmaceuticals UK) for adults with ...
Vera Therapeutics’ atacicept (Trutakna) has secured FDA approval for the treatment of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results